Cargando…

Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona

Detalles Bibliográficos
Autores principales: Zanelli, S., Fiorio, E., Zampiva, I., Zacchi, F., Borghesani, G., Giontella, E., Parolin, V., Biondani, P., Zuliani, S., Dieci, M.V., Mioranza, E., Zorzi, M., Conti, M., Gibellini, D., Verlato, G., Milella, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904004/
https://www.ncbi.nlm.nih.gov/pubmed/35276335
http://dx.doi.org/10.1016/j.annonc.2022.02.227
_version_ 1784664866644033536
author Zanelli, S.
Fiorio, E.
Zampiva, I.
Zacchi, F.
Borghesani, G.
Giontella, E.
Parolin, V.
Biondani, P.
Zuliani, S.
Dieci, M.V.
Mioranza, E.
Zorzi, M.
Conti, M.
Gibellini, D.
Verlato, G.
Milella, M.
author_facet Zanelli, S.
Fiorio, E.
Zampiva, I.
Zacchi, F.
Borghesani, G.
Giontella, E.
Parolin, V.
Biondani, P.
Zuliani, S.
Dieci, M.V.
Mioranza, E.
Zorzi, M.
Conti, M.
Gibellini, D.
Verlato, G.
Milella, M.
author_sort Zanelli, S.
collection PubMed
description
format Online
Article
Text
id pubmed-8904004
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-89040042022-03-09 Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona Zanelli, S. Fiorio, E. Zampiva, I. Zacchi, F. Borghesani, G. Giontella, E. Parolin, V. Biondani, P. Zuliani, S. Dieci, M.V. Mioranza, E. Zorzi, M. Conti, M. Gibellini, D. Verlato, G. Milella, M. Ann Oncol Letter to the Editor European Society for Medical Oncology. Published by Elsevier Ltd. 2022-06 2022-03-09 /pmc/articles/PMC8904004/ /pubmed/35276335 http://dx.doi.org/10.1016/j.annonc.2022.02.227 Text en © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Zanelli, S.
Fiorio, E.
Zampiva, I.
Zacchi, F.
Borghesani, G.
Giontella, E.
Parolin, V.
Biondani, P.
Zuliani, S.
Dieci, M.V.
Mioranza, E.
Zorzi, M.
Conti, M.
Gibellini, D.
Verlato, G.
Milella, M.
Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona
title Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona
title_full Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona
title_fullStr Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona
title_full_unstemmed Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona
title_short Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona
title_sort risk and severity of sars-cov-2 infection in breast cancer patients undergoing a structured infection screening program at the university and hospital trust of verona
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904004/
https://www.ncbi.nlm.nih.gov/pubmed/35276335
http://dx.doi.org/10.1016/j.annonc.2022.02.227
work_keys_str_mv AT zanellis riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT fiorioe riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT zampivai riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT zacchif riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT borghesanig riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT giontellae riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT parolinv riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT biondanip riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT zulianis riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT diecimv riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT mioranzae riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT zorzim riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT contim riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT gibellinid riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT verlatog riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona
AT milellam riskandseverityofsarscov2infectioninbreastcancerpatientsundergoingastructuredinfectionscreeningprogramattheuniversityandhospitaltrustofverona